Cargando…
Making progress in early breast cancer: Taking time or accepting risk?
Outcomes for patients diagnosed with early breast cancer in developed countries have improved substantially over recent decades. Adjuvant therapies have contributed to this improvement and their benefits have been confirmed in large randomised controlled trials (RCTs) and meta-analyses. Lower event...
Autores principales: | Mannu, Gurdeep S., Dodwell, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446260/ https://www.ncbi.nlm.nih.gov/pubmed/28411447 http://dx.doi.org/10.1016/j.ejca.2017.03.005 |
Ejemplares similares
-
Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
por: Forster, Alice S., et al.
Publicado: (2016) -
Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study
por: Mannu, Gurdeep S, et al.
Publicado: (2020) -
Ki67 and breast cancer mortality in women with invasive breast cancer
por: Probert, Jake, et al.
Publicado: (2023) -
Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study
por: Taylor, Carolyn, et al.
Publicado: (2023) -
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
por: Kerr, Amanda J., et al.
Publicado: (2022)